Earnings Preview: Groupon Inc, BioCryst Pharmaceuticals, Inc., and Cablevision Systems Corporation

Analyzing pre-earnings option trends on Groupon Inc (NASDAQ:GRPN), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), and

Aug 6, 2015 at 12:17 PM
facebook twitter linkedin


A number of notable names are making big post-earnings moves today, including Herbalife Ltd. (NYSE:HLF), Keurig Green Mountain Inc (NASDAQ:GMCR), and Tesla Motors Inc (NASDAQ:TSLA). Tomorrow could be more of the same, with coupon concern Groupon Inc (NASDAQ:GRPN), drugmaker BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), and cable operator Cablevision Systems Corporation (NYSE:CVC) all on deck. Below, we'll take the pre-earnings temperature of GRPN, BCRX, and CVC.

  • Over the past eight quarters, GRPN has swung -- on average -- 15% in the session subsequent to reporting. This time around, the equity's near-term at-the-money (ATM) straddle is forecasting a slimmer 13.9% move. Option traders have been betting on the action to resolve itself to the upside following tonight's results, per GRPN's 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 7.58 -- in the 92nd annual percentile. Simply stated, calls have been bought to open over puts with more rapidity just 8% of the time within the past year. Technically speaking, Groupon Inc could use a shot in the arm, considering the shares are down 42.5% year-to-date to trade at $4.75 -- and notched a new two-year low of $4.62 on Monday.

  • BCRX has been on fire since hitting an annual low of $7.85 in late March -- up 82% at $14.32, and fresh off a July 20 eight-year high of $16.83. Nevertheless, put buyers have been active ahead of tomorrow morning's scheduled event, as evidenced by the security's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.79, which rests just 10 percentage points from a 12-month peak. Those currently purchasing the equity's short-term options are paying relatively inflated premiums, considering BCRX's 30-day ATM implied volatility of 72.5% ranks above 77% of all comparable readings taken in the past year. Historically speaking, BioCryst Pharmaceuticals, Inc. has averaged a single-session post-earnings move of 6.7% in the past eight quarters, much less than the 12% the stock's near-term ATM straddle is pricing in for this go-round.

  • Option traders have been quick to initiate long calls over puts on CVC in the lead-up to tomorrow morning's earnings report. Specifically, the security's 10-day ISE/CBOE/PHLX call/put volume ratio of 69.33 rests higher than 94% of all other readings taken in the last 52 weeks. Meanwhile, CVC's short-term options are pricing in extremely high volatility expectations at the moment. In fact, the equity's Schaeffer's Volatility Index (SVI) of 74% stands at an annual high. Looking back over the past eight quarters, Cablevision Systems Corporation has moved an average of 3.4% in the session after reporting, but in tomorrow's session, the equity's near-term ATM straddle is pricing in a much bigger 14.4% swing. On the charts, the security popped higher in late May on sector-related M&A buzz, and has yet to look back. In fact, the shares tagged a 14-year high of $28.95 one week ago, and were last seen lingering near $26.11.
 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners